Today: 21 May 2026
Reliance Industries share price in focus as Russian oil pullback report and Australia deal set up Monday trade
8 February 2026
1 min read

Reliance Industries share price in focus as Russian oil pullback report and Australia deal set up Monday trade

Mumbai, Feb 9, 2026, 02:44 IST — The market has closed.

  • Reliance finished Friday’s session 0.53% higher, closing at 1,451 rupees on the NSE
  • Refiners such as Reliance are steering clear of new Russian crude offers for March-April loadings, according to Reuters.
  • Reliance’s consumer division has clinched a majority stake in Goodness Group, the Australian company known for its “better-for-you” beverages.

Expect Reliance Industries to draw attention on Monday, with a Reuters report flagging that Indian refiners—Reliance among them—are skipping fresh Russian crude deals for March and April shipments. On Friday, Reliance finished up 0.53% at 1,451 rupees on the NSE.

The oil story’s key here: Reliance’s massive refining and fuels arm lives or dies by swings in crude costs and discounts. Should this shift hold, expect traders to argue over what it’ll do to refining margins—the difference between what fuels fetch and what crude demands.

Investors are also watching Reliance’s ongoing consumer products expansion, this time with a renewed focus abroad. The challenge: can these new acquisitions ramp up quickly enough to make an impact, and do so without diverting attention?

Reliance Consumer Products has picked up a majority stake in Sydney’s Goodness Group Global, the owner of Nexba and PACE—the latter a hydration drink co-developed with Australian cricket captain Pat Cummins. “A bold step,” is how RCPL director T. Krishnakumar described the partnership, adding it furthers ambitions to build a global FMCG player. Goodness Group founder Troy Douglas said the company was “thrilled” to bring Reliance on board as a strategic partner.

The deal size wasn’t revealed. The company framed the partnership as a move for broader distribution and expansion, saying Reliance’s consumer arm will support pushing into fresh markets, India among them.

Heading into Monday, the mood holds steady—though no one’s unwinding just yet. Rupak De, senior technical analyst at LKP Securities, set Nifty’s support at 25,500 and resistance up near 25,700. Centrum Broking’s Nilesh Jain flagged a constructive weekly chart as volatility dialed down.

For Reliance, oil market developments could easily overshadow retail chatter at the open. Shifts in crude price spreads between Russian and Middle Eastern grades are key for refiners. Government signals on sourcing will also be closely watched.

Risks cut both ways here. Russian oil? This isn’t a locked-in policy—refiners might pivot fast if they want. As for the consumer play, it’s tiny compared to the energy and telecom heavyweights in the group, and rolling out brands is tricky; these things don’t catch on overnight.

Eyes are turning to the India-U.S. trade discussions, with an interim deal outlining tariff tweaks that, according to a Reuters report, might come into play after the pact is inked in March. For Reliance, any new signals on trade terms or developments in energy links could shape sentiment early in the week.

Stock Market Today

  • Oxford Lane Capital's 24.6% Dividend Hides Deeper Trouble
    May 21, 2026, 10:45 AM EDT. Oxford Lane Capital Corporation (OXLC) offers a striking 24.6% forward dividend yield, drawing investor attention with promises of high income. However, the closed-end fund's share price has plummeted over 73% and dividend payments have declined nearly 41% in five years, eroding investor returns despite hefty payouts. The fund's underlying holdings in risky collateralized loan obligations (CLOs), derivatives linked to complex debt instruments, add significant volatility. Over 15 years, OXLC's net asset value (NAV) has dropped dramatically, highlighting sustained portfolio struggles. Investors relying solely on yield overlook the steep capital losses and ongoing risks in this fund's investment strategy, underlining the hazards of chasing outsized dividends in volatile credit markets.

Latest articles

GlobalFoundries Stock Jumps On U.S. Quantum Funding: Why GFS Is Back In Focus

GlobalFoundries Stock Jumps On U.S. Quantum Funding: Why GFS Is Back In Focus

21 May 2026
NEW YORK, May 21, 2026, 10:08 (EDT) GlobalFoundries shares jumped 12.7% to $79.75 in Thursday morning trading, with volume already above 3.4 million shares, as investors moved into the stock after a fresh U.S. push into quantum-chip manufacturing. The Nasdaq-listed shares opened at $77.99 and touched $82.44, according to market data. The move matters now because Washington is putting capital, not just policy language, behind quantum computing, a still-early technology that uses quantum bits rather than ordinary binary bits to tackle some calculations. For GlobalFoundries, a foundry — a company that makes chips designed by other companies — the funding
Mister Car Wash Stock Drops Off Nasdaq After $3.1 Billion Deal

Mister Car Wash Stock Drops Off Nasdaq After $3.1 Billion Deal

21 May 2026
Mister Car Wash shares have stopped trading after Leonard Green & Partners closed its $3.1 billion take-private deal. Public shareholders will receive $7.00 per share in cash; the stock last traded at $7.10 on May 19. The company will be delisted from Nasdaq and has been removed from the S&P SmallCap 600, replaced by F&G Annuities & Life.
Apellis Stock Disappears From Nasdaq as Biogen $41 Billion Buyout Faces Final Hurdle

Apellis Stock Disappears From Nasdaq as Biogen $41 Billion Buyout Faces Final Hurdle

21 May 2026
Biogen completed its $5.3 billion acquisition of Apellis Pharmaceuticals, ending APLS trading on Nasdaq as of May 15. Former Apellis shareholders receive $41 per share in cash and a contingent value right tied to future Syfovre sales. Biogen shares rose 0.6% early Thursday. The CVR pays only if Syfovre meets specific sales milestones; there is no guarantee of payout.
Utilities stocks week ahead: XLU price ends higher, but CPI and jobs data loom
Previous Story

Utilities stocks week ahead: XLU price ends higher, but CPI and jobs data loom

Novo Nordisk Class B stock: what to watch after Hims pulls $49 Wegovy pill copy
Next Story

Novo Nordisk Class B stock: what to watch after Hims pulls $49 Wegovy pill copy

Go toTop